Author | Brandon May


Daclatasvir-Sofosbuvir-Ribavirin Combination Similar to VEL/SOF Plus RBV for Hepatitis C Genotypes

November 07, 2018

Treatment regimens comprised of DCV+SOF±RBV and VEL/SOF+RBV offer similar cure rates among HCV patients with genotypes 2 and 3.

VA Corporate Data Proves To Accurate Source for HCV Treatment Assessment

October 03, 2018

This observational data could serve an important role in pharmacoepidemiologic studies that would assess the overall benefit and risks of modern HCV therapies, namely direct-acting antivirals.

Gastrointestinal Comorbidities Increase Risk of C Difficile for Patients with UTIs

September 25, 2018

Female sex, previous gastrointestinal, and non-gastrointestinal comorbidities are associated with C difficile infection in women with UTIs, study finds.

Intervention Improves Practices Among Nurses Managing Hospitalized Patients with C Difficile

September 20, 2018

A face-to-face, case-specific education intervention improved the management practices among nurses who cared for hospitalized patients with C difficile infections.